Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Stay tuned
View:
Post by Trogarzon on Oct 12, 2024 4:36pm

Stay tuned

He said stay tuned for the couple next PRs that could be linked to new products for their distribution channel.  The pharma deprioritized drug avenue and the late stage specialty drug avenue.  Immediately accretive or almost.  Prepare to be amazed..
Comment by Trogarzon on Oct 12, 2024 4:54pm
I think the guy was genuine on the call and that they are working on making things right in the short term.  The CFO was  very unapologistic for anything and rebuffing analysts on Marathon question... we don't need to.... I liked the tone.  Only Christian was'nt very moving but then again they can't send messages to the market before results are out.
Comment by SPCEO1 on Oct 14, 2024 4:34pm
A generic version fo Egrifta would still need to be approved by the FDA and no firm has as yet indicated they are going to try to get that approval. Also, I believe there is some FDA rle that makes it difficult to pursue such a generic approval while the FDA is considering a new version of the drug. While the F8 version has yet to be resubmitted, I suspect the FDA is still considered to be in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities